These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37148502)

  • 1. Intermittent Fasting Alleviates Non-Alcoholic Steatohepatitis by Regulating Bile Acid Metabolism and Promoting Fecal Bile Acid Excretion in High-Fat and High-Cholesterol Diet Fed Mice.
    Lin X; Zhu X; Xin Y; Zhang P; Xiao Y; He T; Guo H
    Mol Nutr Food Res; 2023 Jul; 67(14):e2200595. PubMed ID: 37148502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soyasaponin A
    Xiong F; Zheng Z; Xiao L; Su C; Chen J; Gu X; Tang J; Zhao Y; Luo H; Zha L
    Mol Nutr Food Res; 2021 Jul; 65(14):e2100067. PubMed ID: 34047448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stigmasterol Protects Against Steatohepatitis Induced by High-Fat and High-Cholesterol Diet in Mice by Enhancing the Alternative Bile Acid Synthesis Pathway.
    Xin Y; Li X; Zhu X; Lin X; Luo M; Xiao Y; Ruan Y; Guo H
    J Nutr; 2023 Jul; 153(7):1903-1914. PubMed ID: 37269906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice.
    Li X; Zhao W; Xiao M; Yu L; Chen Q; Hu X; Zhao Y; Xiong L; Chen X; Wang X; Ba Y; Guo Q; Wu X
    J Ethnopharmacol; 2022 Aug; 294():115333. PubMed ID: 35500802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high-dose of ursodeoxycholic acid treatment alleviates liver inflammation by remodeling gut microbiota and bile acid profile in a mouse model of non-alcoholic steatohepatitis.
    Li H; Wang M; Chen P; Zhu M; Chen L
    Biomed Pharmacother; 2024 May; 174():116617. PubMed ID: 38643542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary cholesterol drives the development of nonalcoholic steatohepatitis by altering gut microbiota mediated bile acid metabolism in high-fat diet fed mice.
    Gao X; Lin X; Xin Y; Zhu X; Li X; Chen M; Huang Z; Guo H
    J Nutr Biochem; 2023 Jul; 117():109347. PubMed ID: 37031879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flaxseed Powder Attenuates Non-Alcoholic Steatohepatitis via Modulation of Gut Microbiota and Bile Acid Metabolism through Gut-Liver Axis.
    Yang C; Wan M; Xu D; Pan D; Xia H; Yang L; Sun G
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH.
    Hernandez GV; Smith VA; Melnyk M; Burd MA; Sprayberry KA; Edwards MS; Peterson DG; Bennet DC; Fanter RK; Columbus DA; Steibel JP; Glanz H; Immoos C; Rice MS; Santiago-Rodriguez TM; Blank J; VanderKelen JJ; Kitts CL; Piccolo BD; La Frano MR; Burrin DG; Maj M; Manjarin R
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G582-G609. PubMed ID: 32003601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salidroside improves high-fat diet-induced non-alcoholic steatohepatitis by regulating the gut microbiota-bile acid-farnesoid X receptor axis.
    Li H; Xi Y; Xin X; Tian H; Hu Y
    Biomed Pharmacother; 2020 Apr; 124():109915. PubMed ID: 31986416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pure total flavonoids from citrus attenuate non-alcoholic steatohepatitis via regulating the gut microbiota and bile acid metabolism in mice.
    He B; Jiang J; Shi Z; Wu L; Yan J; Chen Z; Luo M; Cui D; Xu S; Yan M; Zhang S; Chen Z
    Biomed Pharmacother; 2021 Mar; 135():111183. PubMed ID: 33401222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile acids contribute to the development of non-alcoholic steatohepatitis in mice.
    Gillard J; Clerbaux LA; Nachit M; Sempoux C; Staels B; Bindels LB; Tailleux A; Leclercq IA
    JHEP Rep; 2022 Jan; 4(1):100387. PubMed ID: 34825156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterozygous knockout of Bile salt export pump ameliorates liver steatosis in mice fed a high-fat diet.
    Okushin K; Tsutsumi T; Ikeuchi K; Kado A; Enooku K; Fujinaga H; Yamauchi N; Ushiku T; Moriya K; Yotsuyanagi H; Koike K
    PLoS One; 2020; 15(8):e0234750. PubMed ID: 32785220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice.
    Rao A; Kosters A; Mells JE; Zhang W; Setchell KD; Amanso AM; Wynn GM; Xu T; Keller BT; Yin H; Banton S; Jones DP; Wu H; Dawson PA; Karpen SJ
    Sci Transl Med; 2016 Sep; 8(357):357ra122. PubMed ID: 27655848
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Liu L; Deng L; Wei W; Li C; Lu Y; Bai J; Li L; Zhang H; Jin N; Li C; Zhao C
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydromyricetin ameliorated nonalcoholic steatohepatitis in mice by regulating the composition of serous lipids, bile acids and ileal microflora.
    Miao X; Luo P; Liu J; Wang J; Chen Y
    Lipids Health Dis; 2023 Aug; 22(1):112. PubMed ID: 37533083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary fat and gut microbiota interactions determine diet-induced obesity in mice.
    Kübeck R; Bonet-Ripoll C; Hoffmann C; Walker A; Müller VM; Schüppel VL; Lagkouvardos I; Scholz B; Engel KH; Daniel H; Schmitt-Kopplin P; Haller D; Clavel T; Klingenspor M
    Mol Metab; 2016 Dec; 5(12):1162-1174. PubMed ID: 27900259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between 12α-hydroxylated bile acids and hepatic steatosis in rats fed a high-fat diet.
    Hori S; Abe T; Lee DG; Fukiya S; Yokota A; Aso N; Shirouchi B; Sato M; Ishizuka S
    J Nutr Biochem; 2020 Sep; 83():108412. PubMed ID: 32534424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of fibroblast growth factor 15 deficiency on the development of high fat diet induced non-alcoholic steatohepatitis.
    Schumacher JD; Kong B; Pan Y; Zhan L; Sun R; Aa J; Rizzolo D; Richardson JR; Chen A; Goedken M; Aleksunes LM; Laskin DL; Guo GL
    Toxicol Appl Pharmacol; 2017 Sep; 330():1-8. PubMed ID: 28673684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STARD1 promotes NASH-driven HCC by sustaining the generation of bile acids through the alternative mitochondrial pathway.
    Conde de la Rosa L; Garcia-Ruiz C; Vallejo C; Baulies A; Nuñez S; Monte MJ; Marin JJG; Baila-Rueda L; Cenarro A; Civeira F; Fuster J; Garcia-Valdecasas JC; Ferrer J; Karin M; Ribas V; Fernandez-Checa JC
    J Hepatol; 2021 Jun; 74(6):1429-1441. PubMed ID: 33515644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters.
    Sun L; Pang Y; Wang X; Wu Q; Liu H; Liu B; Liu G; Ye M; Kong W; Jiang C
    Acta Pharm Sin B; 2019 Jul; 9(4):702-710. PubMed ID: 31384531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.